Indo Us Bio-Tech Share Price Today | Stock Price & Indo Us Bio-Tech Share Screener
As of October 5, 2026, the live Indo Us Bio-Tech share price (NSE: INDOUS) is ₹75.50 on NSE and ₹75.20 on BSE, down 1.63% from the previous close, with shares trading between ₹74.15 and ₹81.00 in today's trading session, and a 52-week range of ₹75.50–₹150.72. Check INDOUS annual price range for the annual price range and momentum. Use the Indo Us Bio-Tech stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Indo Us Bio-Tech opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Indo Us Bio-Tech Share Price Chart
Track the current stock price of Indo Us Bio-Tech with an interactive chart. Analyse INDOUS share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Indo Us Bio-Tech stock quote in one place.
The quote of ₹75.50 sits between the 52-week low of ₹75.50 and the 52-week high of ₹150.72, and the latest session moved -1.63% from the previous close.
Indo Us Bio-Tech Company Profile - Fundamental Screener
Screen Indo Us Bio-Tech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for INDOUS shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the FMCG sector and the Agricultural Products industry, and it trades under ISIN INE250Z01010.
Company Details
Classification
Identifiers and Leadership
Indo Us Bio-Tech Balance Sheet Screener
Screen INDOUS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2022, total assets were ₹56, up from ₹44 in 2021.
Latest statistics put total assets at ₹56 and shareholder funds at ₹39, with a leverage ratio of 0.41.
| Item | 2022 | 2021 | 2020 |
|---|---|---|---|
Assets |
|||
| Total Assets | 56 | 44 | 35 |
| Current Assets | 47 | 38 | 32 |
| Fixed Assets | 6 | 2 | 1 |
Liabilities |
|||
| Total Liabilities | 0 | 0 | 0 |
| Current Liabilities | 5 | 4 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 |
Shareholders' Equity |
|||
| Total Equity | 39 | 21 | 16 |
| Share Capital | 9 | 6 | 6 |
| Reserves & Surplus | 29 | 15 | 10 |
Indo Us Bio-Tech Income Statement Screener - Profit & Revenue Analysis
Screen Indo Us Bio-Tech income statement and profit fundamentals. Analyze INDOUS quarterly results. Indo Us Bio-Tech reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹0 and net profit was ₹0.
In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2022-March, shows revenue of ₹50 and net profit of ₹5.
| Item | None-None | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|
Revenue and Expenses | ||||
| Revenue | 0 | 50 | 40 | 40 |
| Expenses | 0 | 43 | 35 | 36 |
Operating Costs and Margins | ||||
| EBITDA | 0 | 7 | 5 | 4 |
| Operating Profit % | 0.00% | 14.00% | 13.00% | 10.00% |
| Depreciation | 0 | 1 | 0 | 0 |
| Interest | 0 | 1 | 1 | 1 |
Profit and Earnings | ||||
| Profit Before Tax | 0 | 5 | 4 | 3 |
| Tax | 0 | 0 | -1 | 0 |
| Net Profit | 0 | 5 | 5 | 3 |
| EPS | 0.00 | 8.27 | 8.07 | 4.18 |
Indo Us Bio-Tech Cash Flow Screener - Liquidity Fundamentals
Screen INDOUS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2022-March, operating activities generated ₹3.
Over the same period, investing activities used ₹5 and financing activities provided ₹3.
| Item | 2022-March | 2021-March | 2020-March |
|---|---|---|---|
Cash from Operations and Investing | |||
| Operating Activities | 3 | 0 | -1 |
| Investing Activities | -5 | -2 | -1 |
Financing and Net Cash | |||
| Financing Activities | 3 | 2 | 2 |
| Net Cash Flow | 0 | 0 | 0 |
Indo Us Bio-Tech Shareholding Pattern Screener
See Indo Us Bio-Tech shareholding pattern with promoter, FII, and DII holdings. Check Indo Us Bio-Tech promoter holding and ownership changes for INDOUS on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 68.29%, foreign institutions 0.18%, domestic institutions 0.00% and the public 24.46%, spread across 4,531 shareholders.
The shareholder count was 4,531 in 2026-Mar, compared with 4,690 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 68.29% | 68.29% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% |
Institutional Investors | ||||||||
| FII Holding | 0.18% | 0.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 24.46% | 24.51% | 24.34% | 24.36% | 24.14% | 23.69% | 24.43% | 24.42% |
| Other Holding | 7.07% | 7.19% | 5.49% | 5.47% | 5.69% | 6.13% | 5.40% | 5.40% |
| Shareholder Count | 4,531 | 4,690 | 2,780 | 3,112 | 4,130 | 4,738 | 1,183 | 1,133 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Indo Us Bio-Tech. Indo Us Bio-Tech dividend yield can be compared with peers and other stocks in the market.
Indo Us Bio-Tech Stock Index Membership - Nifty & Sensex
See which indices include Indo Us Bio-Tech stock. Check INDOUS index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Indo Us Bio-Tech Market Events Screener - Corporate Actions
Get Indo Us Bio-Tech corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Indo Us Bio-Tech stock events that may affect INDOUS share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 30, 2026, with a record date of September 30, 2026.
It is followed by Quarterly Result Announcement dated August 12, 2026 and Quarterly Result Announcement dated May 29, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-30 | 2026-09-30 | Annual General Meeting | NA | -2.01% |
| 2026-08-12 | 2026-08-12 | Quarterly Result Announcement | NA | -3.07% |
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | -1.72% |
| 2026-01-21 | 2026-01-21 | Quarterly Result Announcement | NA | -5.30% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -3.79% |
| 2025-09-30 | 2025-09-30 | Annual General Meeting | NA | -8.69% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -3.16% |
| 2025-05-26 | 2025-05-26 | Quarterly Result Announcement | NA | -0.39% |
| 2025-02-11 | 2025-02-11 | Quarterly Result Announcement | NA | -1.51% |
| 2024-12-03 | 2024-12-03 | Dividend | ₹ 0.25 /share | 22.71% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -7.20% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | -11.18% |
| 2023-09-30 | 2023-09-30 | Annual General Meeting | NA | 3.60% |
| 2023-08-29 | 2023-08-29 | Bonus | 1:1 | 37.96% |
| 2021-11-29 | Bonus | 1:5 | - |
Indo Us Bio-Tech Competitors Screener - Peer Stocks Comparison
Screen INDOUS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the FMCG sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| LT Foods | 13,987 | 22.16 | 11,023 | 25.69% | 625 | 36.68 |
| KRBL | 8,840 | 11.56 | 6,168 | 9.07% | 648 | 41.32 |
| Gujarat Ambuja Exports | 7,419 | 17.66 | 5,836 | 24.30% | 304 | 46.79 |
| Trualt Bioenergy | 3,931 | 24.60 | 1,814 | -7.85% | 97 | 62.70 |
| Kaveri Seed Company | 3,817 | 16.00 | 1,424 | 13.81% | 296 | 48.84 |
| Sanstar | 2,121 | 62.12 | 785 | -27.46% | 35 | 39.44 |
| Amir Chand Jagdish Kumar (Exports) | 2,093 | 16.82 | 2,287 | 14.13% | 103 | 56.22 |
| GRM Overseas | 1,632 | 21.69 | 1,806 | 31.41% | 76 | 33.72 |
| Avt Natural Products | 1,404 | 15.77 | 727 | 27.04% | 65 | 55.81 |
| Chaman Lal Setia Exports | 1,404 | 11.38 | 1,450 | -3.56% | 115 | 40.96 |
Indo Us Bio-Tech Company Announcements - News & Reports Screener
Screen INDOUS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 5, 2026.
The next most recent announcements are dated September 6, 2026 and September 5, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-05 | Closure of Trading Window | - |
| 2026-09-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-05 | Reg. 34 (1) Annual Report. | - |
| 2026-09-05 | Intimation Of Book Closure For The Purpose Of 22Nd AGM Pursuant To Regulation 42 Of SEBI (LODR) | - |
| 2026-09-05 | Shareholder Meeting- AGM On Sep 30 2026 | - |
| 2026-09-05 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Saturday 05Th September 2026. | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-12 | Results- Financial Results For June 30 2026 | - |
| 2026-08-12 | Board Meeting Outcome for Outcome Of Board Meeting Held On August 12 2026 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. | - |
| 2026-08-05 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | - |
| 2026-08-05 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-08-04 | Board Meeting Intimation for (A) The Unaudited Financial Results For The Quarter Ended On June 30 2026 Pursuant To Regulation 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015; (B) Other Corporate Matters. | - |
| 2026-07-15 | Revised Outcome Of The Board Meeting Held On 10 July 2026. Reconstitution Of Committees. | - |
| 2026-07-15 | Revised: Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations 2015. Ref.: Mail From [email protected] On 13.07.2026 Subject: Resignation Of Statutory Auditor And Appointment Of New Statutory Aud | - |
| 2026-07-10 | Board Meeting Outcome for Change In Composition Of Committees Of The Board. Outcome Of Board Meeting Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-07-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-07-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-04 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | - |
| 2026-07-03 | Board Meeting Outcome for Outcome Of The Board Meeting Held On 3Rd July 2026. | - |
| 2026-06-29 | Closure of Trading Window | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹75.50, within a 52-week range of ₹75.50 to ₹150.72. The P/B ratio is 3.49. Market capitalisation stands at ₹155.24 Cr. The company operates in the FMCG sector, in the Agricultural Products industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 3 balance sheet periods, 4 income statement periods, 3 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.